Latest filing published 14 Apr 2026 for Knight Therapeutics Inc., €91k.
Michael Joseph Tremblay is a declared insider of Knight Therapeutics Inc., with filings sourced from SEDI. Between 7 May 2019 and 10 April 2026, the trades on record add up to 4 filings.
Both buying and selling appear: 1 purchase worth €7,086, against 1 sale worth €94k. Taken together, the sales exceed the purchases by €87k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 option exercise. So far in 2026, the count stands at no purchases and 1 sale.
On 14 April 2026 came the latest disclosure, an option exercise for €91k in Knight Therapeutics Inc. The latest purchase dates back some time: it was published 1,978 days ago, on 27 May 2021. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations